| Literature DB >> 36266471 |
Carina Seah1,2,3, Michael S Breen1, Tom Rusielewicz4, Heather N Bader1,5,6, Changxin Xu1,5,6, Christopher J Hunter4, Barry McCarthy4, P J Michael Deans3, Mitali Chattopadhyay1,5,6, Jordan Goldberg4, Frank Desarnaud1,5,6, Iouri Makotkine1,5,6, Janine D Flory1,5,6, Linda M Bierer1,5,6, Migle Staniskyte1,5,6, Scott A Noggle4, Laura M Huckins1,3, Daniel Paull7, Kristen J Brennand8,9,10, Rachel Yehuda11,12,13,14.
Abstract
Post-traumatic stress disorder (PTSD) can develop following severe trauma, but the extent to which genetic and environmental risk factors contribute to individual clinical outcomes is unknown. Here, we compared transcriptional responses to hydrocortisone exposure in human induced pluripotent stem cell (hiPSC)-derived glutamatergic neurons and peripheral blood mononuclear cells (PBMCs) from combat veterans with PTSD (n = 19 hiPSC and n = 20 PBMC donors) and controls (n = 20 hiPSC and n = 20 PBMC donors). In neurons only, we observed diagnosis-specific glucocorticoid-induced changes in gene expression corresponding with PTSD-specific transcriptomic patterns found in human postmortem brains. We observed glucocorticoid hypersensitivity in PTSD neurons, and identified genes that contribute to this PTSD-dependent glucocorticoid response. We find evidence of a coregulated network of transcription factors that mediates glucocorticoid hyper-responsivity in PTSD. These findings suggest that induced neurons represent a platform for examining the molecular mechanisms underlying PTSD, identifying biomarkers of stress response, and conducting drug screening to identify new therapeutics.Entities:
Year: 2022 PMID: 36266471 DOI: 10.1038/s41593-022-01161-y
Source DB: PubMed Journal: Nat Neurosci ISSN: 1097-6256 Impact factor: 28.771